Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of DKK 206.90 billion. The enterprise value is 230.53 billion.
Market Cap | 206.90B |
Enterprise Value | 230.53B |
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | May 13, 2024 |
Share Statistics
Coloplast has 224.84 million shares outstanding. The number of shares has increased by 5.87% in one year.
Shares Outstanding | 224.84M |
Shares Change (YoY) | +5.87% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 5.72% |
Owned by Institutions (%) | 24.27% |
Float | 141.99M |
Valuation Ratios
The trailing PE ratio is 41.65 and the forward PE ratio is 34.58. Coloplast's PEG ratio is 3.43.
PE Ratio | 41.65 |
Forward PE | 34.58 |
PS Ratio | 7.86 |
PB Ratio | 12.52 |
P/FCF Ratio | 137.84 |
PEG Ratio | 3.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.63, with an EV/FCF ratio of 153.59.
EV / Earnings | 46.41 |
EV / Sales | 8.76 |
EV / EBITDA | 27.63 |
EV / EBIT | 32.01 |
EV / FCF | 153.59 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 148.41.
Current Ratio | 0.85 |
Quick Ratio | 0.53 |
Debt / Equity | 148.41 |
Debt / EBITDA | 2.94 |
Debt / FCF | 16.34 |
Interest Coverage | 9.13 |
Financial Efficiency
Return on equity (ROE) is 43.17% and return on invested capital (ROIC) is 12.92%.
Return on Equity (ROE) | 43.17% |
Return on Assets (ROA) | 10.76% |
Return on Capital (ROIC) | 12.92% |
Revenue Per Employee | 1.64M |
Profits Per Employee | 310,069 |
Employee Count | 15,692 |
Asset Turnover | 0.63 |
Inventory Turnover | 2.36 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.22% in the last 52 weeks. The beta is 0.32, so Coloplast's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | +17.22% |
50-Day Moving Average | 882.87 |
200-Day Moving Average | 852.36 |
Relative Strength Index (RSI) | 56.43 |
Average Volume (20 Days) | 197,682 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of DKK 26.30 billion and earned 4.97 billion in profits. Earnings per share was 22.09.
Revenue | 26.30B |
Gross Profit | 17.76B |
Operating Income | 7.20B |
Pretax Income | 6.32B |
Net Income | 4.97B |
EBITDA | 8.08B |
EBIT | 7.20B |
Earnings Per Share (EPS) | 22.09 |
Balance Sheet
The company has 887.00 million in cash and 24.52 billion in debt, giving a net cash position of -23.64 billion or -105.13 per share.
Cash & Cash Equivalents | 887.00M |
Total Debt | 24.52B |
Net Cash | -23.64B |
Net Cash Per Share | -105.13 |
Equity (Book Value) | 16.52B |
Book Value Per Share | 73.49 |
Working Capital | -1.83B |
Cash Flow
In the last 12 months, operating cash flow was 2.60 billion and capital expenditures -1.10 billion, giving a free cash flow of 1.50 billion.
Operating Cash Flow | 2.60B |
Capital Expenditures | -1.10B |
Free Cash Flow | 1.50B |
FCF Per Share | 6.68 |
Margins
Gross margin is 67.52%, with operating and profit margins of 27.38% and 18.88%.
Gross Margin | 67.52% |
Operating Margin | 27.38% |
Pretax Margin | 24.02% |
Profit Margin | 18.88% |
EBITDA Margin | 30.73% |
EBIT Margin | 27.38% |
FCF Margin | 5.71% |
Dividends & Yields
This stock pays an annual dividend of 21.00, which amounts to a dividend yield of 2.28%.
Dividend Per Share | 21.00 |
Dividend Yield | 2.28% |
Dividend Growth (YoY) | 5.00% |
Years of Dividend Growth | 11 |
Payout Ratio | 95.03% |
Buyback Yield | -5.87% |
Shareholder Yield | -3.59% |
Earnings Yield | 2.40% |
FCF Yield | 0.73% |
Stock Splits
The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.
Last Split Date | Dec 19, 2012 |
Split Type | Forward |
Split Ratio | 5 |